Literature DB >> 16011604

What dose of recombinant activated factor VII should be used in patients with factor XI deficiency?

S A Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16011604     DOI： 10.1111/j.1365-2516.2005.01120.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  2 in total

1.  Uneventful cesarean delivery with administration of factor XI concentrate in a patient with severe factor XI deficiency.

Authors:  Georgios Mavromatidis; Konstantinos Dinas; Dimitrios Delkos; Fotios Goutzioulis; Christos Vosnakis; Emmanouel Hatzipantelis; Vassilia Garipidou; David Rousso
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

2.  Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.

Authors:  Zekai Avci; Baris Malbora; Mahmut Gokdemir; Suleyman Ozkan; Namik Ozbek
Journal:  Pediatr Cardiol       Date:  2007-09-20       Impact factor: 1.655
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.